Related Experiment Video
Updated: May 6, 2026

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
Published on: June 9, 2022
Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic
Rebecca Rose1, Peter V Markov, Tommy T Lam
1Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, United Kingdom.
Insights
Human genetic variations in Central Africa influence hepatitis C virus (HCV) drug treatment success for specific genotypes. This study proposes an ancient evolutionary adaptation of HCV to human genetics, now impacting modern antiviral therapy effectiveness.
Area of Science:
- Evolutionary biology
- Virology
- Human genetics
Background:
- Hepatitis C virus (HCV) is a global pathogen.
- Human genetic polymorphisms in Central Africa correlate with HCV drug treatment outcomes.
- This correlation is genotype-specific, lacking an evolutionary explanation.
Purpose of the Study:
- To propose an evolutionary explanation for the genotype-specific association between human polymorphisms and HCV drug treatment success.
- To investigate the ancient origins of HCV's 'drug treatment resistance' phenotype.
Main Methods:
- Comparative analysis of HCV genotypes and human genetic variation data.
- Phylogenetic analysis to infer evolutionary history.
- Literature review of virological and medical studies on HCV and human polymorphisms.
Main Results:
- The 'drug treatment resistance' in some HCV genotypes likely evolved centuries to millennia ago.
- This evolution was driven by adaptation to local Central African human genetic variation.
- This ancient adaptation has been exapted for a new function in the era of antiviral drugs.
Conclusions:
- HCV's interaction with human genetics has deep evolutionary roots.
- Viral exaptation at the population level offers a novel perspective on pathogen adaptation.
- Understanding this historical context is crucial for current and future HCV treatment strategies.
Abstract:
Specific human polymorphisms, most commonly found in Central Africa, can predict the success of drug treatment against the hepatitis C virus (HCV), a significant and globally-distributed human pathogen. However, this association is only found for a subset of HCV genotypes. Despite receiving considerable attention in the medical and virological literature, no evolutionary explanation for this curious pattern has been put forward. Here we suggest that the 'drug treatment resistance' phenotype exhibited today by some HCV genotypes evolved hundreds to thousands of years ago in response to human genetic variation local to Central Africa: an adaptation that has since accrued a new function in the era of anti-viral drug treatment. This could represent one of the oldest known examples of viral exaptation at the population level.
Related Concept Videos
Viral Mutations
Hepatitis
Viral Hepatitis I: Introduction
Viral Recombination
Principles of Pharmacogenetics: Types of Genetic Variants
Human Virome

